Chlorine Dioxide Eye Drops for Broad-Spectrum Infection Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for conjunctivitis, particularly bacterial, viral, and fungal infections, are inadequate due to antibiotic resistance, lack of effective antimicrobial agents, and impractical diagnostic methods, leading to suboptimal treatment and potential spread of viral conjunctivitis.

Innovation Solution

Compositions containing effective amounts of chlorine dioxide for topical administration to the eye, which are ophthalmically acceptable and effective against bacterial, viral, and fungal infections, including those caused by Mycobacteria, viruses, fungi, or amoebae, providing broad-spectrum antimicrobial activity without detrimental effects on the eye.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic drops are used to treat bacterial conjunctivitis, then bacterial infections can be treated, but antibiotic resistance develops making treatments ineffective

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidantibiotic resistance
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical parameter from traditional antibiotics to chlorine dioxide, which has different mechanisms of action against microorganisms. This parameter change allows effective treatment of bacterial conjunctivitis without contributing to antibiotic resistance, as chlorine dioxide works through oxidation rather than targeting specific bacterial pathways that bacteria can develop resistance to.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent applies chlorine dioxide as a universal antimicrobial agent that can treat multiple types of conjunctivitis (bacterial, viral, fungal) with a single composition. This multi-functional approach replaces the need for different antibiotic drops for different bacterial infections and adds activity against viruses and fungi, thereby reducing overall antibiotic usage and resistance development.

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If conventional ophthalmic treatments are used, then specific bacterial infections can be treated, but they are ineffective against viral and fungal conjunctivitis

Engineering Contradiction:
Improvespectrum of activityVSAvoidtreatment effectiveness
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent employs chlorine dioxide as a broad-spectrum antimicrobial that simultaneously addresses bacterial, viral, and fungal conjunctivitis. The composition achieves universal activity through its oxidative mechanism that disrupts cellular structures across different microorganism types, providing reliable treatment effectiveness across multiple infection types with a single agent.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The patent creates a composite ophthalmic composition containing chlorine dioxide combined with ophthalmic-compatible carriers and stabilizers. This composite formulation maintains the broad-spectrum antimicrobial activity of chlorine dioxide while ensuring safety and compatibility for ocular application, thereby achieving both versatility and reliability.

Inventive Principle:
Principle #40Composite materials

3Measurement precision

If accurate diagnosis through laboratory culture is performed, then precise identification of causative agents is achieved, but the cost and complexity become prohibitive for average healthcare practices

Engineering Contradiction:
Improvediagnostic accuracyVSAvoidlaboratory equipment requirements
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent promotes a diagnostic approach using disposable, point-of-care testing devices that can identify common conjunctivitis pathogens without requiring complex laboratory infrastructure. These simplified testing tools provide sufficient diagnostic accuracy for clinical decision-making while being affordable and easy to integrate into average healthcare practices, eliminating the need for expensive laboratory culture equipment.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

4Object-affected harmful factors

If steroids are used to reduce inflammation in ocular infection, then severity of inflammation is reduced, but susceptibility to infections increases

Engineering Contradiction:
Improveinflammation severityVSAvoidinfection susceptibility
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent combines anti-inflammatory steroids with broad-spectrum antimicrobial chlorine dioxide in a single ophthalmic composition. This merging allows simultaneous reduction of inflammation severity through steroid action while preventing increased infection susceptibility through chlorine dioxide's antimicrobial activity, thereby achieving both benefits without the harmful trade-off.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The chlorine dioxide compositions effectively treat and prevent microbial infections in the eye by reducing or eliminating microbial loads, offering a safer and more effective alternative to existing treatments with improved antimicrobial activity and reduced resistance risks.

Implementation Method 1

Chlorine dioxide is a safe, effective broad-spectrum antimicrobial, anti-viral, and anti-fungal

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS20210177890A1Composition containing chlorine dioxide and methods for using same
Publication Date: 2021.06.17 PAMEL GREGORY J

AI summary

The present invention relates to a composition comprising chlorine dioxide useful in the treatment of active infections of the eye, as well as prophylaxis and treatment of such infections. The invention also relates to uses of compositions including effective amounts of chlorine dioxide in the eye to obtain benefit without detrimentally affecting the eye.